CurrentCardio
Get Weekly

Topic · page 5 of 28

Coronary disease & ACS

Acute and chronic coronary syndromes, MI, INOCA/ANOCA, revascularisation strategy, antithrombotic therapy after ACS/PCI, chest-pain diagnostics

Briefs 161–200 of 1,104 placed here, newest publication first

Briefs in Coronary disease & ACS

Newest publication first

  1. JACC Adv

    Risks of Exogenous Sex Hormone Therapy Before and After Spontaneous Coronary Artery Dissection

    Cohort study

  2. JAMA Cardiol

    Dual Antiplatelet Therapy Duration in Patients at High Bleeding Risk: A Systematic Review and Meta-Analysis

    Meta-analysis

  3. JAMA Intern Med

    Multilevel Stewardship Intervention for Use of Anticoagulation-Antiplatelet Therapy

    Cohort study

  4. Lancet

    Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial

    Randomised controlled trial

  5. Am Heart J

    Reconsidering fibrinolysis in selected patients with non–ST-elevation acute coronary syndrome: A hypothesis-generating, research-based framework

    Research article

  6. Eur Heart J Acute Cardiovasc Care

    Inflammation in coronary syndromes in clinical practice: a clinical consensus statement of the Association for Acute Cardiovascular Care of the European Society of Cardiology, the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases, the European Society of Cardiology Council on Basic Cardiovascular Science, and the European Society of Cardiology Council for Cardiology Practice

    Guideline or statement

  7. Circ Popul Health Outcomes

    Association Between Temporal Changes in Life’s Simple 7 Cardiovascular Health Metrics and Recurrent Coronary Heart Disease in the Atherosclerosis Risk in Communities (ARIC) Study

    Research article

  8. Circ Popul Health Outcomes

    DNR Status and Hospital Mortality Measures Postmyocardial Infarction: Differentiating Preventable From Unpreventable Deaths in CMS Data

    Cohort study

  9. Eur J Prev Cardiol

    Long-term exposure to bushfire-related fine particulate matter and coronary plaque burden in asymptomatic adults

    Cohort study

  10. Eur Heart J

    Micro-axial flow pump vs veno-arterial extracorporeal membrane oxygenation for high-risk percutaneous coronary interventions: a randomized trial

    Randomised controlled trial

  11. Eur Heart J

    Plasma infrared molecular fingerprinting stratifies residual risk in coronary artery disease and reflects clonal haematopoiesis-associated biology

    Diagnostic or prognostic study

  12. JACC Adv

    Lesion-Level Association Between Artificial Intelligence–Derived Coronary Calcium Volume and Plaque Vulnerability

    Cohort study

  13. Eur Heart J Qual Care Clin Outcomes

    Validated 1-year mortality prediction in patients with three-vessel disease undergoing contemporary percutaneous coronary intervention: insights from the Multivessel TALENT trial

    Secondary analysis

  14. JACC Cardiovasc Interv

    A Multidomain Lifestyle Intervention for Invasively Confirmed ANOCA: The SAMCRO Randomized Trial

    Randomised controlled trial

  15. JACC Cardiovasc Interv

    SGLT2 Inhibitor on Infarct Size and LV Remodeling by CMR in Patients With AMI

    Randomised controlled trial

  16. JACC Cardiovasc Interv

    Timing of Bleeding and Ischemic Events in High–Bleeding Risk Patients Treated With 1-Month DAPT

    Cohort study

  17. Eur Heart J Acute Cardiovasc Care

    Beyond A and B: exploring a novel dynamic electrocardiogram change in Wellens syndrome

    Cohort study

  18. JACC Adv

    Specificity of the Occlusion Myocardial Infarction-Trained PMcardio “Queen of Hearts” AI-ECG in Inflammatory Myopericardial Syndromes

    Cohort study

  19. JACC Adv

    Association Between Cardiovascular Risk Factors and Pan-Coronary Plaque Burden, Phenotype, and Vulnerability: A 3-Vessel Imaging Study

    Mechanistic study

  20. Circ Cardiovasc Imaging

    Quantitative CZT SPECT Myocardial Blood Flow for Physiological Assessment and Risk Stratification of Cardiac Allograft Vasculopathy

    Cohort study

  21. Eur J Prev Cardiol

    Baseline anaemia and short dual antiplatelet therapy in high bleeding risk patients undergoing percutaneous coronary intervention

    Meta-analysis

  22. Eur Heart J

    Standard clinical and stress electrocardiogram variables to exclude left main and left main-equivalent disease: the MASTER study

    Case-control study

  23. Eur J Prev Cardiol

    Beta-blocker therapy after acute coronary syndrome in patients without heart failure or reduced ejection fraction: a target-trial emulation study

    Cohort study

  24. JACC Adv

    Prognostication of Acute Kidney Injury Following Percutaneous Coronary Intervention: A Machine Learning Approach

    Cohort study

  25. JACC Adv

    Randomized Feasibility Trial of Routine Versus Selective Transesophageal Echocardiography During Isolated Coronary Artery Bypass Grafting

    Randomised controlled trial

  26. Heart

    Drug-coated balloons versus drug-eluting stents for de novo coronary lesions: a systematic review and meta-analysis of randomised trials

    Meta-analysis

  27. Circ Cardiovasc Interv

    Temporal Trends and Predictors of Access Site Crossover During PCI in Contemporary Practice: A Report From the NCDR CathPCI Registry

    Cohort study

  28. EuroIntervention

    Endotype-guided medical therapy and symptom response in ANOCA

    Cohort study

  29. JACC Cardiovasc Imaging

    Comparison of Photon-Counting and Energy-Integrating Computed Coronary Tomography Angiography for Coronary Artery Disease: A Systematic Review and Meta-Analysis

    Meta-analysis

  30. JACC Adv

    Intracoronary Imaging Implementation Gap in Contemporary PCI: The OCT2ACT Study

    Cohort study

  31. Circ Cardiovasc Interv

    Antithrombotic Therapy in Patients With Atrial Fibrillation With Prior Complex PCI: A Secondary Analysis of the Randomized ADAPT AF-DES Trial

    Secondary analysis

  32. JACC Cardiovasc Interv

    Clopidogrel vs Aspirin According to Diabetes Mellitus: A Prespecified Analysis of the SMART-CHOICE 3 Trial

    Secondary analysis

  33. J Am Coll Cardiol

    Long-Term Exposure to PM2.5 Constituents and Coronary Heart Disease Risk in China

    Cohort study

  34. J Am Coll Cardiol

    Myocardial Scar Assessment Using Artificial Intelligence-Powered Contrast-Free MRI: A Prospective Multicenter Study of Virtual Native Enhancement

    Diagnostic or prognostic study

  35. Lancet

    1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial

    Randomised controlled trial

  36. Eur J Prev Cardiol

    Obesity and cardiovascular outcomes after myocardial infarction: a nationwide SWEDEHEART analysis by diabetes status

    Cohort study

  37. JACC Adv

    Technical and Target Lesion Failure in Calcified Coronary Lesions: Residual Risk Beyond Successful Lithotripsy

    Cohort study

  38. Eur Heart J

    Micro- and nano-plastics in the coronary circulation and air pollution exposure in ischaemic heart disease presentation

    Cross-sectional study

  39. Eur Heart J Cardiovasc Imaging

    Comprehensive assessment of vasospastic angina using coronary computed tomography angiography: synergistic value of the presence of myocardial bridge, perivascular inflammation, and myocardial extracellular volume fraction

    Research article

  40. JACC Adv

    Impact of Coronary Microvascular Dysfunction on Patient-Reported Symptoms After PCI

    Research article

All 1,104 Briefs in ExploreShowing Briefs 161–200 of 1,104, newest first